Cannabis and Biotech Board Chair Arrested for Securities Fraud
Cannabis Law Report
AUGUST 6, 2021
He was board chairman at Arch from 2013 to 2018 and OncoSec from 2011 to 2020. From 2005 to 2009, Dhillon was chief executive officer of Inovio Pharmaceuticals Inc. According to the government, Dhillon concealed from regulators his ownership of millions of shares in Arch Therapeutics Inc. and OncoSec Medical Inc.,
Let's personalize your content